Gold Nanostars Take SERS Inside the Biofilm
Steven Bell explains how – and why – he’s tracking antibiotic diffusion in living biofilms
By
James Strachan
January 15, 2026
Clinical Scorecard: Gold Nanostars Take SERS Inside the Biofilm
At a Glance
Category Detail
Condition Biofilm-associated bacterial infections Key Mechanisms Surface-enhanced Raman spectroscopy (SERS) for real-time observation of antibiotic diffusion Target Population Patients with infections involving biofilms, such as those with implanted medical devices, wound infections, and UTIs Care Setting Clinical and research settings focused on antimicrobial treatment
Key Highlights
Gold nanostars embedded in biofilms allow for real-time measurement of antibiotic diffusion. Transport rates of antibiotics in biofilms are significantly lower than in aqueous environments. 80% of human bacterial infections involve biofilms, highlighting their clinical significance. SERS provides a method to study biofilm responses to antimicrobial treatments. Potential for application in monitoring chemical changes within biofilms. Guideline-Based Recommendations
Diagnosis
Consider biofilm presence in chronic infections and treatment failures. Management
Utilize SERS to assess antibiotic penetration and effectiveness in biofilm infections. Monitoring & Follow-up
Monitor biofilm responses to antimicrobial agents and environmental changes using SERS. Risks
Increased tolerance of biofilm-encased bacteria to antibiotics may complicate treatment. Patient & Prescribing Data
Patients with infections related to biofilms, particularly those with medical implants.
Understanding antibiotic diffusion can inform treatment strategies and improve outcomes.
Clinical Best Practices
Incorporate SERS technology for better understanding of biofilm dynamics. Focus on developing novel antimicrobial delivery systems targeting biofilms. Related Resources & Content
